OncoMed Pharmaceuticals Inc. (NASDAQ: OMED) announced today it will present data from several clinical programs at the upcoming American Society ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE